Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02954952 · ClinicalTrials.gov registry record · NA

EEG Data Collection to Evaluate New Patient State Index Performance

A NA study, sponsored by Masimo Corporation.

Terminated
Registry status
NA
Development phase
44
Enrollment target

NCT02954952 is a NA study that was terminated before completion, run by Masimo Corporation. The registered enrollment target is 44 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02954952, a NA study, was terminated before completion, sponsored by Masimo Corporation.

TERMINATED
Registry status
NA
Development phase
44 participants
Enrollment target

Study Summary

This is a prospective, single-center, cohort study in patients undergoing surgical procedures to collect data using Masimo SedLine EEG device in order to evaluate a newer version of PSI measurement against an older version of PSI measurement.

Interventions

  • DEVICE PSI Rev 1.X
  • DEVICE PSI Rev 2.X

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2016-11-11
Est. Completion 2018-01-11
Phase NA

Sponsor

Masimo Corporation

96 total trials

What the Registry Record Tells You About NCT02954952

The ClinicalTrials.gov registry entry for NCT02954952 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which PSI Rev 1.X is the first listed.

NCT02954952 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02954952 about?

NCT02954952 is a clinical study titled "EEG Data Collection to Evaluate New Patient State Index Performance". This is a prospective, single-center, cohort study in patients undergoing surgical procedures to collect data using Masimo SedLine EEG device in order to evaluate a newer version of PSI measurement against an older version of PSI measurement.

What is the current status of trial NCT02954952?

This trial is currently terminated. It is a NA study. The enrollment target is 44 participants. The study started on 2016-11-11. Estimated completion is 2018-01-11.

What interventions are being tested in trial NCT02954952?

The interventions under investigation include: PSI Rev 1.X (DEVICE), PSI Rev 2.X (DEVICE).

Who is sponsoring clinical trial NCT02954952?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.